Literature DB >> 19737272

Systemic antibiotics in periodontal therapy.

L J A Heitz-Mayfield1.   

Abstract

Periodontitis is a biofilm infection with a mixed microbial aetiology. Periodontitis is generally treated by non-surgical mechanical debridement and regular periodontal maintenance care. Periodontal surgery may be indicated for some patients to improve access to the root surface for mechanical debridement. A range of systemic antibiotics for treatment of periodontitis has been documented, with some studies showing superior clinical outcomes following adjunctive antibiotics while others do not. This has resulted in controversy as to the role of systemic antibiotics in the treatment of periodontal diseases. Recent systematic reviews have provided an evidence-based assessment of the possible benefits of adjunctive antibiotics in periodontal therapy. This review aims to provide an update on clinical issues of when and how to prescribe systemic antibiotics in periodontal therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737272     DOI: 10.1111/j.1834-7819.2009.01147.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  16 in total

1.  Periodontology: antibiotics protocol.

Authors:  A Dziedzic; R D Wojtyczka
Journal:  Br Dent J       Date:  2014-12       Impact factor: 1.626

Review 2.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

Review 3.  Should Antibiotics Be Prescribed to Treat Chronic Periodontitis?

Authors:  John Walters; Pin-Chuang Lai
Journal:  Dent Clin North Am       Date:  2015-08-01

4.  Benefits of early systemic antibiotics in localized aggressive periodontitis: a retrospective study.

Authors:  Dennis Beliveau; Ingvar Magnusson; John A Bidwell; Edward F Zapert; Ikramuddin Aukhil; Shannon M Wallet; Luciana M Shaddox
Journal:  J Clin Periodontol       Date:  2012-08-29       Impact factor: 8.728

5.  Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro.

Authors:  C J Doyle; T R Fitzsimmons; C Marchant; A A S S K Dharmapatni; R Hirsch; P M Bartold
Journal:  Clin Oral Investig       Date:  2014-05-08       Impact factor: 3.573

6.  Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.

Authors:  Tahereh Sadat Jafarzadeh Kashi; Solmaz Eskandarion; Mehdi Esfandyari-Manesh; Seyyed Mahmoud Amin Marashi; Nasrin Samadi; Seyyed Mostafa Fatemi; Fatemeh Atyabi; Saeed Eshraghi; Rassoul Dinarvand
Journal:  Int J Nanomedicine       Date:  2012-01-10

Review 7.  Amoxicillin/Metronidazole Dose Impact as an Adjunctive Therapy for Stage II - III Grade C Periodontitis (Aggressive Periodontitis) at 3- And 6-Month Follow-Ups: a Systematic Review and Meta-Analysis.

Authors:  Malihe Karrabi; Zahra Baghani
Journal:  J Oral Maxillofac Res       Date:  2022-03-31

Review 8.  Regenerative Potential of Enamel Matrix Protein Derivative and Acellular Dermal Matrix for Gingival Recession: A Systematic Review and Meta-Analysis.

Authors:  Muhammad Saad Shaikh; Mohid Abrar Lone; Hesham Matabdin; Muneeb Ahmed Lone; Azeem Hussain Soomro; Muhammad Sohail Zafar
Journal:  Proteomes       Date:  2021-02-25

Review 9.  Antibiotic Prescribing for Oro-Facial Infections in the Paediatric Outpatient: A Review.

Authors:  Najla Dar-Odeh; Hani T Fadel; Shaden Abu-Hammad; Rua'a Abdeljawad; Osama A Abu-Hammad
Journal:  Antibiotics (Basel)       Date:  2018-04-25

10.  Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT.

Authors:  Raluca Cosgarea; S Eick; S Jepsen; N B Arweiler; R Juncar; R Tristiu; G E Salvi; C Heumann; A Sculean
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.